Episode Details

Back to Episodes
Eli Lilly Shocks Wall Street: Global Demand for Weight-Loss Drugs Sends Forecast Soaring!

Eli Lilly Shocks Wall Street: Global Demand for Weight-Loss Drugs Sends Forecast Soaring!

Published 4 months, 1 week ago
Description

Eli Lilly has raised its full-year forecast after unprecedented international demand for its hit weight-loss and diabetes drugs, Mounjaro and Zepbound. The pharmaceutical giant’s booming sales and rapid global expansion signal a new era for obesity treatment worldwide.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us